Melanoma Journal Articles for June 2020

Annals of Surgical Oncology

Published: 01 June 2020

Oncological outcome of videoscopic groin dissection for lymph node metastasis from melanoma

Surgical Endoscopy (2020) https://doi.org/10.1007/s00464-020-07675-5

Clinical Cancer Research

PD-1 Blockade in Chinese versus Western Patients with Melanoma

Alexander N Shoushtari, Riyue Bao and Jason J. Luke

Add to Cart ($35)

DOI: 10.1158/1078-0432.CCR-20-1558

Future Medicine

Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review

Georgia Kyriakou & Maria Melachrinou

Published Online:2 Jun 2020 https://doi.org/10.2217/fon-2020-0151

Published: 02 June 2020

Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

Annals of Surgical Oncology (2020) https://doi.org/10.1245/s10434-020-08648-7

Dove Press

Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors – Results of a Prospective Biomarker Study

Authors Forschner A, Weißgraeber S, Hadaschik D, Schulze M, Kopp M, Kelkenberg S, Sinnberg T, Garbe C, Biskup S, Battke F

Received 3 February 2020

Accepted for publication 9 April 2020

Published 4 June 2020 Volume 2020:13 Pages 5017—5032

DOI https://doi.org/10.2147/OTT.S248237

Cureus

Acral Lentiginous Melanoma: A Rare Variant With Unique Diagnostic Challenges

Brett C. Brazen, Taylor Gray, Maheera Farsi, Richard Miller

Published: June 03, 2020 (see history)

DOI: 10.7759/cureus.8424

MDPI Sensors

Proposal of the CAD System for Melanoma Detection Using Reconfigurable Computing

Wysterlânya K. P. Barros 1 , Daniel S. Morais 1 , Felipe F. Lopes 1 , Matheus F. Torquato 2 , Raquel de M. Barbosa 3,† and Marcelo A. C. Fernandes 1

Received: 25 March 2020; Accepted: 29 May 2020; Published: 3 June 2020

Sensors 2020, 20, 3168; doi:10.3390/s20113168

International Journal of Molecular Sciences

The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma

by Sathyen A. Prabhu^1,2,†,Omar Moussa^1,2,†,Wilson H. Miller, Jr.^1,2,3,4,5 andSonia V. del Rincón^1,

Int. J. Mol. Sci. 2020, 21(11), 4055; https://doi.org/10.3390/ijms21114055 (registering DOI)

Received: 11 May 2020 / Revised: 28 May 2020 / Accepted: 29 May 2020 / Published: 5 June 2020

(This article belongs to the Special Issue Signaling in Melanoma)

International Journal of Molecular Sciences

Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors

by Magdalena Olbryt^*,Marcin Rajczykowski andWies?awa Wid?ak

Int. J. Mol. Sci. 2020, 21(11), 4071; https://doi.org/10.3390/ijms21114071 (registering DOI)

Received: 15 May 2020 / Revised: 1 June 2020 / Accepted: 2 June 2020 / Published: 6 June 2020

(This article belongs to the Special Issue Signaling in Melanoma)

BJD

Clinical, environmental, and histological distribution of BRAF, NRAS and TERT promoter mutations among cutaneous melanoma patients. A retrospective study of 563 patients

Manrique?Silva S. Rachakonda D. Millán?Esteban Z. García?Casado C. Requena V. Través R. Kumar E. Nagore

First published:07 June 2020

https://doi.org/10.1111/bjd.19297

MDPI Cancers

Dual Targeting of BRAF and mTOR Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds

Veronika Palušová 1,2, Tereza Renzová 1 , Amandine Verlande 1 , Tereza Vaclová 1 , Michaela Medková 1 , Linda Cetlová 1 , Miroslava Sedlá?cková 1 , Hana H?ríbková 1 , Iva Slaninová 1 , Miriama Krutá 1 , Vladimír Rotrekl 1,2 , Hana Uhlí?rová 3,4 , Aneta K?rížová 4 , Radim Chmelík 3,4 , Pavel Veselý 4 , Michaela Kraf?cíková 5 , Lukáš Trantírek 6 , Kay Oliver Schink 7,8 and Stjepan Uldrijan 1

Received: 29 February 2020; Accepted: 5 June 2020; Published: 10 June 2020

Cancers 2020, 12, 1516; doi:10.3390/cancers12061516

MDPI Pharmaceutics

Development of a DNA Vaccine for Melanoma Metastasis by Inhalation Based on an Analysis of Transgene Expression Characteristics of Naked pDNA and a Ternary Complex in Mouse Lung Tissues

Yukinobu Kodama 1, Mikiro Nakashima 2, Tadayuki Nagahara 2, Natsuko Oyama 2, Junya Hashizume 1, Hiroo Nakagawa 1, Hitomi Harasawa 1, Takahiro Muro 1, Tomoaki Kurosaki 1, Chikamasa Yamashita 3, Mitsuru Hashida 4, Takashi Kitahara 5, Hitoshi Sasaki 1, Shigeru Kawakami 2 and Tadahiro Nakamura

Received: 6 May 2020; Accepted: 9 June 2020; Published: 11 June 2020

Pharmaceutics 2020, 12, 540; doi:10.3390/pharmaceutics12060540

Prostate?Specific Membrane Antigen expression in melanoma metastases

Hayden Snow Stephen Hazell Nicholas Francis Kabir Mohammed Stephanie O’Neill Emma Davies David Mansfield Christina Messiou Nabil Hujairi David Nicol Kevin Harrington Myles Smith

First published:11 June 2020

https://doi.org/10.1111/cup.13774

Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts

Claus Garbe, MD¹; Ulrike Keim, PhD¹; Stefan Suciu, PhD²; Teresa Amaral, MD¹; Thomas K. Eigentler, MD¹; Anja Gesierich, MD³; Axel Hauschild, MD⁴; Lucie Heinzerling, MD⁵; Felix Kiecker, PhD⁶; Dirk Schadendorf, MD⁷; Rudolf Stadler, MD⁸; Cord Sunderkötter, MD⁹; Thomas Tüting, MD¹⁰; Jochen Utikal, MD¹¹; Uwe Wollina, MD¹²; Christos C. Zouboulis, MD, PhD¹³; Ulrich Keilholz, MD¹⁴; Alessandro Testori, MD¹⁵; Peter Martus, PhD¹⁶; Ulrike Leiter, MD¹; and Alexander M. M. Eggermont, MD, PhD¹⁷ on behalf of the German Central Malignant Melanoma Registry and the European Organisation for Research and Treatment of Cancer

DOI: 10.1200/JCO.19.03034 Journal of Clinical Oncology

Published online June 12, 2020.

Cancer Epidemiology, Biomarkers & Prevention

Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at Diagnosis

Yahya Mahamat-Saleh, Maria Celia B. Hughes, Kyoko Miura, Maryrose K. Malt, Lena von Schuckmann, Kiarash Khosrotehrani, B. Mark Smithers and Adèle C Green

Published OnlineFirst June 12, 2020
doi: 10.1158/1055-9965.EPI-20-0319

Journal of Clinical Oncology

Improved risk prediction calculator for sentinel node positivity in patients with melanoma: The Melanoma Institute Australia nomogram

Serigne N. Lo, PhD^1,2; Jiawen Ma, MD^1,2; Richard A. Scolyer, MD^1,3; Lauren E. Haydu, PhD, MPH⁴; Jonathan R. Stretch, DPhil(Oxon)^1,2,5; Robyn P. M. Saw, MBMS^1,2,5; Omgo E. Nieweg, MD, PhD^1,2,5; Kerwin F. Shannon, MBBS^1,5; Andrew J. Spillane, MD^1,2,6; Sydney Ch’ng, MD, PhD^1,2,5; Graham J. Mann, MBBS, PhD^1,2,7; Jeffrey E. Gershenwald, MD⁴; John F. Thompson, MD^1,2,5; and Alexander H. R. Varey, MBChB, PhD^1,2,8

DOI: 10.1200/JCO.19.02362 Journal of Clinical Oncology

Published online June 12, 2020.

Cancers MDPI

The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments

Theresa Steeb 1,2 , Anja Wessely 1,2 , Konstantin Drexler 3 , Martin Salzmann 4 , Frédéric Toussaint 1,2, Lucie Heinzerling 1,2, Markus Reinholz 5 , Carola Berking 1,2 and Markus V. Heppt

Received: 2 April 2020; Accepted: 17 June 2020; Published: 18 June 2020

Cancers 2020, 12, 1613; doi:10.3390/cancers12061613

Dove Press

Long Noncoding RNA CCAT1 Functions as a Competing Endogenous RNA to Upregulate ITGA9 by Sponging MiR-296-3p in Melanoma

Authors Fan J, Kang X, Zhao L, Zheng Y, Yang J, Li D

Received 5 March 2020

Accepted for publication 22 May 2020

Published 18 June 2020 Volume 2020:12 Pages 4699—4714

DOI https://doi.org/10.2147/CMAR.S252635

MDPI _ Processes

Iron Oxide/Salicylic Acid Nanoparticles as Potential Therapy for B16F10 Melanoma Transplanted on the Chick Chorioallantoic Membrane

Maria Cristina Predoi 1,† , Ion Mîndril? 1,* ,† , Sandra Alice Buteic? 2,† , S, tefana Oana Purcaru 3,† , Dan Eduard Mihaiescu 4 and Ovidiu Marcel M?rginean

Received: 9 May 2020; Accepted: 15 June 2020; Published: 19 June 2020

Annals of Internal Medicine

Malignant Melanoma with Delayed Metastatic Growths

DWIGHT L. WILBUR, M.D., HOWARD R. HARTMAN, M.D., F.A.C.P.

https://doi.org/10.7326/0003-4819-5-2-201

MDPI _ Molecules

Assessment of Raman Spectroscopy for Reducing Unnecessary Biopsies for Melanoma Screening

by Yao Zhang¹,Austin J. Moy¹,Xu Feng¹,Hieu T. M. Nguyen¹,Katherine R. Sebastian²,Jason S. Reichenberg²,Claus O. Wilke³,Mia K. Markey^1,4 and James W. Tunnell^1,*

Molecules 2020, 25(12), 2852; https://doi.org/10.3390/molecules25122852

Received: 21 May 2020 / Revised: 12 June 2020 / Accepted: 18 June 2020 / Published: 20 June 2020

(This article belongs to the Special Issue A New Diagnosis Tool of Cancer by Spectroscopic Analysis)

MDPI – Cancers

Melanoma Brain Metastases in the Era of Target Therapies: An Overview

by Paolo Becco¹,Susanna Gallo^2,*,Stefano Poletto^1,3,Mirko Pio Manlio Frascione^1,3,Luca Crotto¹,Alessandro Zaccagna¹,Luca Paruzzo^1,3,Daniela Caravelli¹,Fabrizio Carnevale-Schianca¹ andMassimo Aglietta

Cancers 2020, 12(6), 1640; https://doi.org/10.3390/cancers12061640

Received: 28 May 2020 / Revised: 16 June 2020 / Accepted: 17 June 2020 / Published: 21 June 2020

(This article belongs to the Special Issue Targeted Therapies for Melanoma)

MDPI_Diagnostics

Simple and Accurate Border Detection Algorithm for Melanoma Computer Aided Diagnosis

by Cataldo Guaragnella andMaria Rizzi^*

Diagnostics 2020, 10(6), 423; https://doi.org/10.3390/diagnostics10060423

Received: 5 May 2020 / Revised: 9 June 2020 / Accepted: 18 June 2020 / Published: 22 June 2020

(This article belongs to the Section Medical Imaging)

Cureus

The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients

Shang-Jui Wang, Sachin R. Jhawar, Zorimar Rivera-Nunez, Ann W. Silk, John Byun, Eric Miller, Dukagjin Blakaj, Rahul R. Parikh, Joseph Weiner, Sharad Goyal

Published: June 22, 2020

DOI: 10.7759/cureus.8767

CUREUS

Checkpoint Inhibitor in a Melanoma Patient With Polyendocrinopathy and Gangrenous Gallbladder With a Mass

Nayson L. Fernandes, Soujanya Sodavarapu, Sukhmine Nedopil, Nikita Mohapatra, Dinesh Vyas

DOI

10.7759/cureus.8786

JEADV

The predictive and prognostic significance of cell?free DNA concentration in melanoma

Váraljai S. Elouali S.S. Lueong K. Wistuba?Hamprecht T. Seremet J.T. Siveke J.C. Becker A. Sucker A. Paschen P.A. Horn B. Neyns B. Weide D. Schadendorf A. Roesch

First published: 22 June 2020 https://doi.org/10.1111/jdv.16766

MDPI – Applied Sciences

A Measurement Software for Professional Training in Early Detection of Melanoma

by Sara Cacciapuoti¹,Giuseppe Di Leo²,Matteo Ferro²,Consolatina Liguori²,Anna Masarà¹,Massimiliano Scalvenzi¹,Paolo Sommella^2,* and Gabriella Fabbrocini¹

Appl. Sci. 2020, 10(12), 4351; https://doi.org/10.3390/app10124351

Received: 19 May 2020 / Revised: 16 June 2020 / Accepted: 22 June 2020 / Published: 24 June 2020

Cancer Immunology research

Distinctive subpopulations of stromal cells are present in human lymph nodes infiltrated with melanoma

Jennifer Eom, Saem Mul Park, Vaughan Feisst, Chun-Jen J Chen, Joanna E Mathy, Julie D McIntosh, Catherine E Angel, Adam Bartlett, Richard Martin, Jon A Mathy, Jonathan S Cebon, Michael A Black, Anna E.S. Brooks and P. Rod Dunbar

DOI: 10.1158/2326-6066.CIR-19-0796

IJC – Cancer Therapy and Prevention

Real?world outcomes of advanced melanoma patients not represented in phase III trials

M.C.T. van Zeijl R.K. Ismail L.C. de Wreede A.J.M. van den Eertwegh A. de Boer M. van Dartel D.L. Hilarius M.J.B. Aarts F.W.P.J. van den Berkmortel M.J. Boers?Sonderen … See all authors

First published: 19 June 2020 https://doi.org/10.1002/ijc.33162

Spandidos Publications – International Journal of Oncology

Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review)

Ond?ej Kodet, Jan Ku?era, Karolína Strnadová, Barbora Dvo?ánková, Ji?í Štork, Lukáš Lacina, Karel Smetana

Published online on: June 26, 2020 https://doi.org/10.3892/ijo.2020.5090

Dove Press

A Review of MicroRNA in Uveal Melanoma

Authors Li YF, Dong L, Li Y, Wei WB

Received 14 March 2020

Accepted for publication 12 June 2020

Published 1 July 2020 Volume 2020:13 Pages 6351—6359

DOI https://doi.org/10.2147/OTT.S253946

MDPI – Cancers

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Celeste Lebbé 1,*, Caroline Dutriaux 2 , Thierry Lesimple 3 , Willem Kruit 4 , Joseph Kerger 5 , Luc Thomas 6 , Bernard Guillot 7 , Filippo de Braud 8 , Claus Garbe 9 , Jean-Jacques Grob 10 , Carmen Loquai 11, Virginia Ferraresi 12, Caroline Robert 13, Paul Vasey 14, Robert Conry 15 , Richard Isaacs 16, Enrique Espinosa 17, Armin Schueler 18, Giorgio Massimini 19 and Brigitte Dréno

Received: 28 May 2020; Accepted: 22 June 2020; Published: 29 June 2020

Cancers 2020, 12, 1727; doi:10.3390/cancers12071727

Theranostics 2020; 10(18):8036-8050. doi:10.7150/thno.45843

Research Paper

JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin ?v?3 signaling

Jiahua Cui^1,2*, Chuanjun Shu^3*, Jin Xu^1,2, Dongyin Chen⁴, Jin Li⁵, Kun Ding^1,2, Minjuan Chen^1,2, Aiping Li^1,2, Jingdong He⁵, Yongqian Shu^2,6, Liuqing Yang⁷, Ruiwen Zhang⁸, Jianwei Zhou^1,2

JAMA Ophthalmology

Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014

Nitya Rajeshuni, MD, MS¹; Talhah Zubair, AB¹; Cassie A. Ludwig, MD, MS¹; et al

JAMA Ophthalmol. Published online July 2, 2020. doi:10.1001/jamaophthalmol.2020.2254

Melanoma Journal Articles for June 2020

Oncological outcome of videoscopic groin dissection for lymph node metastasis from melanoma

PD-1 Blockade in Chinese versus Western Patients with Melanoma

Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review

Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

Acral Lentiginous Melanoma: A Rare Variant With Unique Diagnostic Challenges

The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma

Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors

BJD

Clinical, environmental, and histological distribution of BRAF, NRAS and TERT promoter mutations among cutaneous melanoma patients. A retrospective study of 563 patients

MDPI Cancers

Dual Targeting of BRAF and mTOR Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds

Received: 29 February 2020; Accepted: 5 June 2020; Published: 10 June 2020

Cancers 2020, 12, 1516; doi:10.3390/cancers12061516

MDPI Pharmaceutics

Development of a DNA Vaccine for Melanoma Metastasis by Inhalation Based on an Analysis of Transgene Expression Characteristics of Naked pDNA and a Ternary Complex in Mouse Lung Tissues

Prostate?Specific Membrane Antigen expression in melanoma metastases

Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts

Cancer Epidemiology, Biomarkers & Prevention

Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at Diagnosis

Journal of Clinical Oncology

Improved risk prediction calculator for sentinel node positivity in patients with melanoma: The Melanoma Institute Australia nomogram

Malignant Melanoma with Delayed Metastatic Growths

Assessment of Raman Spectroscopy for Reducing Unnecessary Biopsies for Melanoma Screening

Melanoma Brain Metastases in the Era of Target Therapies: An Overview

Simple and Accurate Border Detection Algorithm for Melanoma Computer Aided Diagnosis

The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients

CUREUS

Checkpoint Inhibitor in a Melanoma Patient With Polyendocrinopathy and Gangrenous Gallbladder With a Mass

DOI

The predictive and prognostic significance of cell?free DNA concentration in melanoma

A Measurement Software for Professional Training in Early Detection of Melanoma

Distinctive subpopulations of stromal cells are present in human lymph nodes infiltrated with melanoma

IJC – Cancer Therapy and Prevention

Real?world outcomes of advanced melanoma patients not represented in phase III trials

JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin ?v?3 signaling

Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014

Our Partners

Melanoma Research Victoria

Quick Links